Bausch + Lomb is a pure-play eye-health company spanning contact lenses and lens care, ophthalmic pharmaceuticals, and surgical products for cataract and vitreoretinal procedures. Its consumer brands (including Biotrue and well-known contact-lens lines) sit alongside prescription drops and surgical devices used by eye-care professionals. The business serves patients, optometrists, ophthalmologists, and retail/pharmacy channels worldwide, with a focus on vision correction, ocular surface disease, and surgical intervention.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,278 | — | -62 | — |
| Q3 2025 | 1,281 | — | -28 | — |
| Q4 2025 | 1,405 | — | -58 | — |
| Q1 2026 | 1,244 | — | -71 | — |
| Q2 2026 | 1,394 | 9.1% | -14 | — |
All markets — KeepWinning global stock screener
Other companies on Toronto (TSX): PrairieSky Royalty Ltd. (PSK), FirstService Corporation (FSV), Open Text Corporation (OTEX), ATCO Ltd. (ACO X), Perseus Mining Limited (PRU), Brookfield Renewable Corporation (BEPC)